Log in with your email address username.


[Correspondence] A closer look at SCOOP: screening for fracture prevention

As part of SCOOP, a pragmatic randomised controlled trial of the effect of a screening programme on incident osteoporotic fractures in 12 483 women aged 70–85 years, Lee Shepstone and colleagues1 reported a relative reduction in hip fractures of 28% (hazard ratio 0·72, 95% CI 0·59–0·89) compared with usual care. This decrease in hip fractures is a remarkable result if one considers that the effect is largely diluted by participants not receiving treatment. 1486 (24%) participants in the screening group received at least one prescription versus 982 (16%) of the control group—a difference in received treatment of 8%.